Loading clinical trials...

RECRUITINGNA

Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis

Effect of Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis: an Exploratory Pilot Study

NCT06364592•Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Summary

The aim of this study is to preliminarily evaluate the is to assess the effects and safety of electroacupuncture for moderate to severe dysmenorrhea secondary to adenomyosis.

Eligibility

Age

18 - 50 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Meeting the diagnosis criteria of dysmenorrhea secondary to adenomyosis.
•Female patients aged between 18 and 50.
•Dysmenorrhea lasting for 3 consecutive menstrual cycles or more.
•At least three consecutive menstrual cycles with an interval of 24 to 38 days, differing by less than 7 days, and menstrual periods lasting 2 to 8 days before screening.
•At least 2 days of worst pain score ≥4 on Numerical Rating Scale during the screening period.
•Having not used medications, other than rescue medicine, or therapies for dysmenorrhea secondary to adenomyosis for at least 1 month before randomization, and consenting not to use throughout the process of the research.
•Volunteering to participate the trial and signing written informed consent.

Exclusion Criteria

•Diagnosed with Endometriosis or having a history of endometriosis-related surgery
•Currently taking hormonal medications, including: a.use of GnRH agonists within 6 months before the screening period; b. use of progestins or danazol and other long-acting hormones within 3 months before the screening period; c. use of oral contraceptive-like short-acting hormones within one month before the screening period;
•Having clinically significant gynecologic condition such as clinically significant endometrial pathology, persistent complex ovarian cyst larger than 3 cm or simple ovarian cyst larger than 5 cm, or single fibroid 4 cm or larger or more than 4 fibroids measuring at least 2 cm or symptomatic submucosal fibroid of any size.
•having an IUD.
•HB \< 90G/L.
•Having any other chronic pain syndrome that required chronic analgesic or other chronic therapy.
•Having a current history of undiagnosed abnormal genital bleeding.
•Malignant tumors (including the reproductive system and other systems).
•Combined with severe diseases in the cardiac, respiratory, renal, liver, and hematopoietic systems, psychiatric disorder and/or cognitive disorders.
•Pregnant, breast feeding, planning a pregnancy within the next 7 months.

Locations (1)

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Beijing, China

Key Dates

Start Date

July 21, 2024

Primary Completion Date

October 31, 2026

Completion Date

December 31, 2026

Last Updated

August 6, 2025

Enrollment

ESTIMATED participants

Conditions

DysmenorrheaAdenomyosisElectroacupuncture

Interventions

Electroacupuncture

DEVICE

Sham Electroacupuncture

DEVICE

Contacts

Zhishun Liu

CONTACT

+861088002331 zhishunjournal@163.com

Min Yang

CONTACT

+8618810268077 yangmin2019@yeah.net

Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

NCT05640232

Primary Dysmenorrhea

View study

RECRUITINGPHASE2/PHASE3

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

NCT07034326

Non-Small Cell Lung CancerElectroacupuncture+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis

Inclusion Criteria

Exclusion Criteria

Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints

Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea

Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea

Risk Factors Associated With the Progression of Adenomyosis